Treatment patterns, outcomes, and resource utilisation of patients with metastatic melanoma in the U.K.: the MELODY study.

Abstract

Advanced melanoma is an aggressive disease with a poor prognosis. Approved therapy is limited in the U.K. and, until recently, no treatment had improved survival over best supportive care. A deeper understanding of current clinical practice will help new agents find a place in future treatment pathways.